Advertisement

Nanomedicine

  • Vinay BhardwajEmail author
  • Roozbeh Nikkhah-Moshaie
Chapter

Abstract

In this chapter, we start with the origin of nanotechnology and nanomedicine and the definition of nanomedicine in the USA and Europe. The size range of nanomedicine is discussed according to different definitions and regulations, and development of nanomedicine from lab to market is reviewed. Nanomaterials for nanomedicine is divided into two categories of polymer-based and metal-based. A brief explanation of most important nanomaterials including liposome, carbohydrates, gold, silver, and iron oxide in drug delivery and release, sensing and imaging are given. Nanomedicines already showed their potential and are promising to cure cancer, neurodegenerative disorders including NeuroHIV, Alzheimer’s, and Parkinson’s.

Keywords

Nanotechnology Nanomedicine Nanomaterials Nanocarriers Drug Delivery 

References

  1. 1.
    Feynman R. There’s plenty of room at the bottom, American Physical Society. Pasadena: Caltech; 1959.Google Scholar
  2. 2.
    Taniguchi N. On the basic concept of nanotechnology. In: International Conference on Product Engineering. Tokyo: Japan Society of Precision Engineering; 1974. p. 18–23.Google Scholar
  3. 3.
    Nanomedicine: grounds for optimism, and a call for papers. The Lancet. 2003;362(9385):673.Google Scholar
  4. 4.
    Nikkhah-Moshaie R, Kaushik A, Jayant RD, Bhardwaj V, Nair M. TEM investigation of nanocarriers distribution in mice brain. Microsc Microanal. 2016;22(S3):1173–2.CrossRefGoogle Scholar
  5. 5.
    Roco MC. National nanotechnology initiative: past, present, future. In: Goddard WA, Brenner DW, Lyshevski SE, Iafrate G, editors. Handbook on nanoscience, engineering and technology. 2nd ed. London: Taylor and Francis; 2007. p. 26.Google Scholar
  6. 6.
    Litzinger DC, Buiting AMJ, Rooijen NV, Huang L. Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta. 1994;1190(1):99–107.CrossRefPubMedGoogle Scholar
  7. 7.
    Nanospectra Biosciences, Inc. Pilot study of Aurolase (tm) therapy in refractory and/or current tumors of the head and neck; 2009.Google Scholar
  8. 8.
    Pillai G. Nanomedicine for cancer therapy: an update of FDA approved and those under various stages of development. SOJ Pharm Pharm Sci. 2014;1(2):13.Google Scholar
  9. 9.
    European Commission. Commission recommendation of XXX on the definition of nanomaterial. Brussels: European Commission; 2011. p. 6.Google Scholar
  10. 10.
    European Union. Regulation (EU) No 528/2012 of the European Parliament and of the council of 22 May 2012 concerning the making available on the market and use of biocidal products, vol. L 167/1. Luxembourg: Office of the European Union; 2012.Google Scholar
  11. 11.
    European Science Foundation. Nanomedicine, An ESF—European Medical Research Councils (EMRC) Forward Look report. Strasbourg cedex, France: ESF; 2005. p. 7.Google Scholar
  12. 12.
    Steinhoff G. Regenerative medicine from protocol to patient. 2nd ed. Dordrecht: Springer; 2013.Google Scholar
  13. 13.
    Venkatraman SS, Ma LL, Natarajan JV, Chattopadhyay S. Polymer- and liposome-based nanoparticles in targeted drug delivery. Front Biosci. 2010;S2:801–14.CrossRefGoogle Scholar
  14. 14.
    Vashist A, Kaushik A, Vashist A, Jayant RD, Tomitaka A, Ahmad S, Gupta YK, Nair M. Recent trends on hydrogel based drug delivery systems for infectious diseases. Biomater Sci. 2016;4:1535–53.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975–99.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Bhardwaj V, Srinivasan S, McGoron AJ. Efficient intracellular delivery and improved biocompatibility of colloidal silver nanoparticles towards intracellular SERS immuno-sensing. Analyst. 2015;140(12):3929–34.CrossRefPubMedGoogle Scholar
  17. 17.
    Srinivasan S, Bhardwaj V, Nagasetti A, Fernandez-Fernandez A, McGoron AJ. Multifunctional surface-enhanced Raman spectroscopy-detectable silver nanoparticles for combined photodynamic therapy and pH-triggered chemotherapy. J Biomed Nanotechnol. 2016;12(12):2202–19.CrossRefGoogle Scholar
  18. 18.
    Kaushik A, Jayant RD, Nikkhah-Moshaie R, Bhardwaj V, Roy U, et al. Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Sci Rep. 2016;6:25309.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kaushik A, Nikkhah-Moshaie R, Bhardwaj V, Sinha R, Alturi V, et al. Investigation of ac-magnetic field stimulated nanoelectroporation of magneto-electric nano-drug-carrier inside CNS cells. Sci Rep. 2017;7:45663.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Kaushik A, Jayant RD, Sagar V, Nair M. The potential of magneto-electric nanocarriers for drug delivery. Expert Opin Drug Deliv. 2014;11(10):1635–46.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Jain PK, Huang X, El-Sayed IH, El-Sayed MA. Noble metal at nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology and medicine. Acc Chem Res. 2008;41(12):1578–86.CrossRefPubMedGoogle Scholar
  22. 22.
    Etheridge ML, Campbell SA, Erdman AG, Haynes CL, Wolf SM, et al. The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine. 2013;9(1):1–14.CrossRefPubMedGoogle Scholar
  23. 23.
    Kaushik A, Jayant RD, Nair M. Advancements in nano-enabled therapeutics for neuroHIV management. Int J Nanomedicine. 2016;11:4317–25.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Jayant RD, Sosa D, Kaushik A, Atluri V, Vashist A, et al. Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv. 2016;13(10):1433–45.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Nair M, Jayant RD, Kaushik A, Sagar V. Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev. 2016;103:202–17.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Biomedical EngineeringRutgers, The State University of New JerseyPiscataway TownshipUSA
  2. 2.Department of ImmunologyHerbert Wertheim College of MedicineSt, MiamiUSA
  3. 3.Center for Personalized NanomedicineFlorida International UniversitySt, MiamiUSA

Personalised recommendations